AR029837A1 - SUBSTITUTED SULPHONIC ACID ANILIDS - Google Patents

SUBSTITUTED SULPHONIC ACID ANILIDS

Info

Publication number
AR029837A1
AR029837A1 ARP010103411A ARP010103411A AR029837A1 AR 029837 A1 AR029837 A1 AR 029837A1 AR P010103411 A ARP010103411 A AR P010103411A AR P010103411 A ARP010103411 A AR P010103411A AR 029837 A1 AR029837 A1 AR 029837A1
Authority
AR
Argentina
Prior art keywords
anilids
sulphonic acid
substituted
cycloalkylalkyl
heterocyclyl
Prior art date
Application number
ARP010103411A
Other languages
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR029837A1 publication Critical patent/AR029837A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Se refiere a nuevas anilidas del ácido sulfonico sustituido de la formula 1 en la que Ra significa hidroxi, nitro, ciano, carbamoilo, tiocarbamoilo, halogeno o significa uno de los agrupamientos siguientes -Rl, -Qa-Rl, -Qa-CQ?-Rl, R? significa alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquilalquilo, arilo, arilalquilo, heterociclilo, o heterociclilalquilo sustituidos respectivamente en caso dado, Rl significa alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquilalquilo, arilo, arilalquilo, heterociclilo o heterociclilalquilo sustituidos respectivamente en caso dado, X significa hidrogeno, ciano o halogeno, y Z significa uno de los agrupamientos heterocíclicos citados en la descripcion, así como a procedimientos para su obtencion y a su empleo como agentes para el tratamiento de las plantas.Refers to new anilides of the substituted sulfonic acid of the formula 1 in which Ra means hydroxy, nitro, cyano, carbamoyl, thiocarbamoyl, halogen or means one of the following groupings -Rl, -Qa-Rl, -Qa-CQ? - Rl, R? means alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heterocyclyl, or heterocyclylalkyl, respectively substituted where appropriate, Rl means alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heterocyclyl, respectively X means hydrogen, cyano or halogen, and Z means one of the heterocyclic clusters cited in the description, as well as procedures for obtaining it and its use as agents for the treatment of plants.

ARP010103411A 2000-07-18 2001-07-17 SUBSTITUTED SULPHONIC ACID ANILIDS AR029837A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2000134803 DE10034803A1 (en) 2000-07-18 2000-07-18 Substituted sulfonic acid anilides

Publications (1)

Publication Number Publication Date
AR029837A1 true AR029837A1 (en) 2003-07-16

Family

ID=7649259

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103411A AR029837A1 (en) 2000-07-18 2001-07-17 SUBSTITUTED SULPHONIC ACID ANILIDS

Country Status (4)

Country Link
AR (1) AR029837A1 (en)
AU (1) AU2001281954A1 (en)
DE (1) DE10034803A1 (en)
WO (1) WO2002006244A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007014114A (en) 2005-05-10 2008-03-14 Intermune Inc Pyridone derivatives for modulating stress-activated protein kinase system.
EP2125750B1 (en) 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5451611B2 (en) 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
JP5490014B2 (en) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド 11β-hydroxysteroid dehydrogenase type 1 cyclic urea inhibitor
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5734666B2 (en) 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ，インコーポレイテッド 1,3-oxaazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1
EP2254872A2 (en) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
JP5301563B2 (en) 2008-05-01 2013-09-25 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
US8569292B2 (en) 2008-05-01 2013-10-29 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
EP2291373B1 (en) 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA3034994A1 (en) 2008-06-03 2009-12-10 Intermune, Inc. Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders
JP5379160B2 (en) 2008-07-25 2013-12-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
JP5777030B2 (en) 2008-07-25 2015-09-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Inhibitor of 11β-hydroxysteroid dehydrogenase 1
EP2393807B1 (en) 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
MA33216B1 (en) 2009-04-30 2012-04-02 Boehringer Ingelheim Int CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
JP5749263B2 (en) 2009-07-01 2015-07-15 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
JP5860042B2 (en) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Substituted 5, 6 and 7 membered heterocycles, medicaments containing such compounds and their use
JP5813106B2 (en) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Azaspirohexanone as an inhibitor of 11-β-HSD1 for the treatment of metabolic disorders
AU2011325286B2 (en) 2010-11-02 2015-04-16 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
EA027324B1 (en) 2011-11-11 2017-07-31 Пфайзер Инк. 2-thiopyrimidinones
AR092742A1 (en) 2012-10-02 2015-04-29 Intermune Inc ANTIFIBROTIC PYRIDINONES
CN106459042B (en) 2014-04-02 2019-06-28 英特穆恩公司 Anti-fibrosis pyridinone
PE20180503A1 (en) 2015-05-05 2018-03-09 Pfizer 2-THIOPYRIMIDINONES
WO2021013800A1 (en) 2019-07-22 2021-01-28 Bayer Aktiengesellschaft Substituted n-phenyl-n-aminouarcils and salts thereof and use thereof as herbicidal agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4303376A1 (en) * 1993-02-05 1994-08-11 Bayer Ag Substituted triazolinones
ES2110667T3 (en) * 1993-08-18 1998-02-16 Bayer Ag N-CIANOARIL-NITROGENATED HETEROCICLES.
CN1100045C (en) * 1993-12-20 2003-01-29 拜尔公司 N-cyanoaryl nitrogen heterocycles with sulphur-containing groupings
US5962372A (en) * 1994-04-25 1999-10-05 Bayer Aktiengesellschaft N-cyanoaryl nitrogen heterocycles
DE4414568A1 (en) * 1994-04-27 1995-11-02 Bayer Ag Heterocyclylbenzonitriles
DE4431219A1 (en) * 1994-09-02 1996-03-07 Bayer Ag Selective herbicides based on aryluracils
DE19632005A1 (en) * 1996-08-08 1998-02-12 Bayer Ag Substituted p-trifluoromethylphenyluracile
AU5710898A (en) * 1996-12-23 1998-07-17 Fmc Corporation Certain 3-{2,4-disubstituted-5-(substituted amino)phenyl}-1-substituted-6-trifluoromethyl-2,4-(1(h),3(h) )-pyrimidinedione derivatives as herbicides
DE19731784A1 (en) * 1997-07-24 1999-02-04 Bayer Ag Substituted N-aryl-N-thioxocarbonyl sulfonamides
AU742108B2 (en) * 1998-04-09 2001-12-20 Bayer Aktiengesellschaft Substituted phenyl pyridazinones

Also Published As

Publication number Publication date
DE10034803A1 (en) 2002-01-31
WO2002006244A1 (en) 2002-01-24
AU2001281954A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
AR029837A1 (en) SUBSTITUTED SULPHONIC ACID ANILIDS
CR7828A (en) OXIALQUILAMIDS OF QUINOLINE, ISOQUINOLINA AND QUINAZOLINA AND ITS USE AS FUNGICIDES
UY28876A1 (en) SUBSTITUTED MORPHOLINE COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
ECSP066717A (en) SUBSTITUTED QUINOLINE COMPOUNDS
PA8680701A1 (en) OXINDOL DERIVATIVES
ECSP077271A (en) PIRIMIDINE DERIVATIVES
ECSP088590A (en) MULTICYCLIC AMINO ACID DERIVATIVES AND THEIR METHODS OF USE
ECSP077259A (en) PIRIMIDINE DERIVATIVES
NI200900093A (en) COMPOUNDS THAT MODULATE THE ACTIVITY OF C-FMS AND / OR C-KIT AND USE OF THE SAME.
CR9716A (en) BENCIMIDAZOLS REPLACED AS CINASA INHIBITORS
SV2001000004A (en) DIFENIL UREAS W-CARBOXYARIL SUBSTITUTED, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THEIR USE AS RAF QUINASA INHIBITORS
CR10090A (en) PIPERAZINE COMPOUNDS WITH HERBICITY ACTION
CO6150138A2 (en) CICLOBUTEN-1,2-DIONAS 3,4-DI-SUBSTITUTED AS CXC CHEMIOKIN RECEIVERS
UY30846A1 (en) OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
PA8541601A1 (en) NEW SPIROCICLIC DERIVATIVES AND ITS USE AS INHIBITORS OF PHOSPHODIESTERASA-7.
UY28150A1 (en) THERAPEUTIC AGENTS
CO6331473A2 (en) DERIVATIVES OF 2,3-DIHYDROBENZO [1,4] DIOXIN-2-ILMETILO AS ALFA2C ANTAGONISTS FOR USE IN THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISEASES
AR029838A1 (en) SUBSTITUTED BENZONITROGEN HETEROCICLES
UY29607A1 (en) CHEMICAL COMPOUNDS
CR7977A (en) TRIFLUOROMETIL-THIOFENCARBOXILIC ACID ANILIDES AND ITS USE AS FUNGICIDES
ECSP088925A (en) SIPROCYCLIC NITRILS AS PROTEASA INHIBITORS
ES2422173T3 (en) Compositions containing aecuorin and procedures for their use
PA8644701A1 (en) DERIVATIVES OF ALQUILIDEN-TETRAHIDRONAFTALENO, PROCEDURE FOR ITS PREPARATION AND ITS USE AS ANTI-INFLAMMATORIES
CR11584A (en) OXINDOL DERIVATIVES SUBSTITUTED AND USE OF THE SAME FOR THE TREATMENT OF VASOPRESINE DEPENDENT DISEASES
GT200800066A (en) DERIVATIVES OF 9-CHLORINE-15-DEOXIPROSTAGLANDIN, PROCEDURE FOR PREPARATION AND USE AS A MEDICINAL PRODUCT.

Legal Events

Date Code Title Description
FB Suspension of granting procedure